Valeant Pharmaceuticals International Inc (NYSE:VRX)

197.48
Delayed Data
As of Feb 27
 -3.77 / -1.87%
Today’s Change
106.00
Today|||52-Week Range
204.66
+37.99%
Year-to-Date
5 Stocks With Jaw-Dropping Growth Potential
Feb 28 / MotleyFool.com
Update: Marathon Pharma Sold Hospital Products To Valeant
Feb 23 / Benzinga
Top 10 News for 2/23 - 2/27: Revised GDP Slips, but Beats, in Q4; Two Pharma Giants t...
Feb 27 / Investing Channel
Cramer: Valeant's Stock Doesn't Stop Here, It Goes Higher
Feb 23 / Benzinga
Whobs Next In The Pharma Buyout Boom?
Feb 26 / Investing Channel
Benzinga's Volume Movers
Feb 23 / Benzinga
3 Stocks Boosting The Drugs Industry Higher
Feb 24 / TheStreet.com
Jim Cramer: Dollar General's Sales Accelerate, Valeant Is Undervalued
Feb 23 / TheStreet.com
Valeant Pharmaceuticals (VRX) Stock Higher Today as Analyst Increases Price Target on...
Feb 24 / TheStreet.com
Stocks Hitting 52-Week Highs
Feb 23 / Benzinga
Jim Cramer on Valeant: This Is an Amazing Pharmaceutical Firm
Feb 24 / TheStreet.com
Morning Market Gainers
Feb 23 / Benzinga
Stock Market News for February 24, 2015 - Market News
Feb 24 / Zacks.com
Valeant Pharmaceuticals Earnings Eclipsed by the Salix Deal - Analyst Blog
Feb 23 / Zacks.com
Valeant Pharmaceuticals (VRX) Earnings Report: Q4 2014 Conference Call Transcript
Feb 24 / TheStreet.com
Notable Mergers and Acquisitions 2/23: (VRX)/(SLXP) (MMM)/(PPO) (AIR)/(TDG) (OCN)/(NS...
Feb 23 / Investing Channel
Pharma ETFs in Focus on Valeant-Salix Deal - ETF News And Commentary
Feb 24 / Zacks.com
Valeant Pharmaceuticals (VRX) Stock Surges Today as Analyst Ups Price Target on Salix...
Feb 23 / TheStreet.com
Jim Cramer Says Investors Should Buy Valeant Pharmaceuticals (VRX) After It Acquired ...
Feb 24 / TheStreet.com
Fed in Focus This Week - Ahead of Wall Street
Feb 23 / Zacks.com
Jim Cramer's Top Stock Picks: AAPL DOW VRX XEC FTK
Feb 24 / TheStreet.com
Monday's #PreMarket Movers: Spectrum Pharmaceuticals, Cyberark Software Trending Down
Feb 23 / Benzinga
Valeant Pharma (VRX) Soars on Salix Buy: 3 Keys for Investors - Stocks in the News
Feb 23 / Zacks.com
Valeant Pharmaceuticals (VRX) Tops Estimates
Feb 23 / Investing Channel
Biotech Stocks Moving Higher
Feb 23 / Benzinga
US Stock Futures Slip Ahead Of Economic Data
Feb 23 / Benzinga
Valeant CEO Explains Why The Company Is Acquiring Salix For $10.1 Billion Cash Instea...
Feb 23 / Benzinga
Frontrunning: February 23
Feb 23 / Investing Channel
Streetinsider.com's Hot Lunchtime Reads 2/23: (OCN) (GOOG) (SPPI) (ABT)
Feb 23 / Investing Channel
Greek Government Under Fire at Home
Feb 23 / TheStreet.com
Why Valeant Pharmaceuticals Int'l Inc.'s Shares Took Off Today
Feb 23 / MotleyFool.com
Greek Government Under Fire at Home
Feb 23 / TheStreet.com
Fastest-Growing Major Pharmaceutical
Feb 23 / TheStreet.com
Must Watch Stocks for Today
Feb 23 / Benzinga
Fastest-Growing Major Pharmaceutical
Feb 23 / TheStreet.com
Valeant Agrees to Buy Salix Pharma for $14.5 Billion in Cash
Feb 22 / TheStreet.com
Valeant Surges on Salix Acquisition: What Wall Street's Saying
Feb 23 / TheStreet.com
Benzinga's Weekend M&A Chatter
Feb 22 / Benzinga

To view my watchlist

Not a member yet?

Sign up now for a free account